Boyds appoints Sharon Mitchell as Clinical Project Manager to support growth in clinical operations
Boyds has strengthened its Clinical Operations team with the appointment of Sharon Mitchell as Clinical Project Manager, supporting the consultancy’s continued growth and expanding portfolio of client projects.
Sharon brings extensive experience across the full clinical development pathway, having started her drug development career as a clinical project assistant before progressing into senior Clinical Research Associate and Project Manager roles within both biotech and pharmaceutical companies. She has worked on numerous Phase I to Phase III clinical trials across a wide range of therapeutic areas and geographic territories, giving her a strong understanding of the operational, regulatory and practical considerations involved in delivering high-quality clinical studies.
In her new role, Sharon will work as part of Boyds’ Clinical Operations team, contributing to a number of ongoing projects while also helping to support the continued expansion of the company’s clinical development services. Her appointment further enhances Boyds’ ability to provide clients with flexible, experienced project management support across complex drug development programs.
Commenting on her appointment, Chris Moore, Director of Clinical Operations at Boyds, said: “We are delighted to welcome Sharon to the team. Her appointment comes at an important time for Boyds as we continue to see significant growth in our clinical operations work and increasing demand from clients for experienced, pragmatic support across their development programs. Sharon’s broad clinical experience, gained across different phases, therapeutic areas and regions, will be a real asset to both our team and our clients. She brings the practical insight, project management expertise and collaborative approach that are essential to delivering successful studies, and we look forward to the valuable contribution she will make as we continue to expand our clinical operations services.”
On joining Boyds, Sharon added: “I am delighted to be joining Boyds at such an exciting stage in its growth. The opportunity to work as part of an inspirational, highly experienced team that is supporting innovative drug development projects really appealed to me, particularly where that work has the potential to make a meaningful difference for patients. Having spent my career working across biotech and pharmaceutical environments, I am looking forward to bringing that experience to the consultancy side and applying it to a broad range of client programs. Boyds has an excellent reputation for combining scientific and clinical expertise with a collaborative, pragmatic approach, and I am excited to contribute to projects that help clients progress their therapies through development and closer to the patients who need them.”